WEREWOLF THERAPEUTICS INC. - COMMON STOCK
1,2300
12-марта-25 15:45:01
15 мин. задержка
Акции
-0,0300
-2,38%
Сегодняшний диапазон
1,2200 - 1,2963
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
07 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
06 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024
05 мар 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic Outlook
08 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference
22 ноя 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
14 ноя 2023 15:25:00 Источник Nasdaq GlobeNewswire
-
31 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
27 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Host KOL Event Highlighting IL-2 Landscape and Opportunity for WTX-124
11 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
05 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
10 авг 2023 06:10:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at the Jefferies Healthcare Conference
01 июн 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
11 май 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Participate in May Investor Conferences
01 май 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
19 апр 2023 09:00:15 Источник Nasdaq GlobeNewswire
-
23 мар 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
UPDATE -- Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2023
16 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2023
15 мар 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
24 фев 2023 06:30:03 Источник Nasdaq GlobeNewswire